Printer Friendly

Articles from The Fly (March 16, 2021)

1-129 out of 129 article(s)
Title Author Type Words
AC Immune reports topline AC1-24 Phase 1b immunogenicity, safety results. 371
Agrify enters binding LOI for build-out of R&D facility in Atlantis partnership. 191
Allied Esports determines Bally's proposal to acquire CSI is a superior offer. 236
Altabancorp responded to Section 13D group statements. 235
Ampio reports 'preliminary positive results' in AP-014 Phase I trial of Ampion. 266
Amtech Systems receives orders for BDF-300 from European chip maker. 178
Amyris signs MOU for partnership with Minerva Foods of Brazil. 167
Anavex announces publication on ANAVEX 2-73 in medical journal. 539
Apollo Global commences tender offer for all oustanding shares of Michaels. 285
Applied Materials unveils playbook for process control based on big data, AI. 473
Aprea Therapeutics reports Q4 EPS (73c), consensus (64c). Financial report 181
Aravive reports Q4 EPS (25c), consensus (52c). Financial report 162
Arch Biopartners gets Health Canada approval to amend Phase II trial protocol. 224
Asian Market Update:. 161
AzurRx announces completion of enrollment in Phase 2b OPTION 2 trial. 228
Bioceres acquires 6% ownership interest in Moolec Science. 172
Biodesix CEO sees 'modest gross margin percentage expansion for 2021'. 216
Cabaletta Bio reports Q4 EPS (40c), consensus (36c). Financial report 155
Calibre Mining announces results of Pavon Open Pit Gold PFS. Financial report 203
Can-Fite signs $42.7M out-licensing deal with Ewopharma. 267
CDW acquires education-focused consultancy Amplified IT, expects accretion. 186
Citi Trends reports Q4 EPS $1.81, consensus $1.74. Financial report 171
CohBar nominates CB5138 analog as lead clinical candidate. 223
Conformis announces data from review of Conformis iTotal knee replacement tech. 326
Continental AG Supervisory Board approves planned spinoff, listing of Vitesco. 208
Coupang down 5% after announcing partial early lock-up release. 242
CSU, Flint Animal Cancer Center applies Sensus' SRT non-surgical treatment. 197
Cue Biopharma reports Q4 EPS (37c), consensus (40c). Financial report 215
CytoSorbents announces filing of IDE for U.S. STAR-T trial. 166
Daqo New Energy enters three-year polysilicon supply agreement with Gaojing. 158
Designer Brands reports Q4 adjusted EPS (53c), consensus (68c). 216
DraftKings announces pricing of $1.1B upsized offering of senior notes. 360
Dream Finders Homes reports Q4 revenue $461.1M, consensus $483.4M. Financial report 246
Dream Finders Homes sees 5,000-6,000 home closings in 2021. 175
Duke Realty announces eight new development transactions in Q1. 246
Dynatrace announces expanded, strategic collaboration pact with Microsoft. 157
Ehang partners with Giancarlo Zema Design Group to build vertiport. 204
ElectraMeccanica announces plans to establish U.S. base in Arizona. 354
Eli Lilly announces mirikizumab met primary, secondary endpoints in LUCENT-1. Clinical report 263
ELMS receives over 45,000 pre-orders for Urban Delivery electric vehicle. 206
eToro to become publicly traded via FinTech Acquisition Corp. V combination. 464
Euronet to purchase Merchant Acquiring business of Piraeus Bank for $360M. 300
Evaxion Biotech announces publication of study on S. aureus Bacterium. 217
Exagen reports Q4 EPS (27c), consensus (40c). Financial report 170
Exxon Mobil urges shareholders to vote blue card for 12 director nominees. 306
Fed policy outlook: markets are focused on the FOMC's forecasts. 162
FirstEnergy enters pact with Icahn Capital to add two new members to board. 183
Flutterwave, PayPal partner to help African merchants accept, make payments. 200
Fly Intel: Top five analyst downgrades. 246
Fly Intel: Top five analyst upgrades. 261
FOMC preview: the Fed is meeting today and announces its decisions Wednesday. 160
Ford announces $2B convertible notes offering. 192
Ford confirms next generation Ford Transit Custom all-electric coming in 2023. 235
FTC plans 'new approach' to analyzing effects of pharmaceutical mergers. 169
FuelCell reports Q1 EPS (15c), consensus (4c). Financial report 259
FX Action: USD-CAD has lifted,. 232
FX Update: Currencies have been trading with stability. 402
FX Update: Currencies have mostly been trading with stability. 378
Global Blood Therapeutics to in-license two SCD programs from Sanofi. 153
GoPro debuts new mobile app Quik with features like 'Mural'. 206
Great Elm Capital reports Q4 NII 7c, two est. 11c. 254
Guardion Health Sciences regains compliance with Nasdaq minimum bid price rule. 277
Hollysys reponds to March 14 press release. 255
II-VI provides details on proposed equity investment from Bain Capital. 571
ImmunoPrecise says 27 lead candidate antibodies analyzed for SARS-CoV-2. 305
Immutep enters second collaboration with Merck for Phase IIB trial in HNSCC. 198
Intel debuts 11th Gen Intel Core S-series desktop processors, Rocket Lake. 164
Just Energy to voluntarily delist common shares from Toronto Stock Exchange. 172
Last U.S. cigarette smoker like to quit by 2050, says Citi. 174
Luckin Coffee enters into restructuring support agreement. 598
MannKind announces closing of inital purchaser's option to purchase senior notes. 529
Marathon Patent Group reports Q4 EPS (10c), one est. (1c). Financial report 290
Medigus says Charging Robotic signs MOU for robotic charging pad distribution. 260
Micron updates data center portfolio strategy. 306
Microsoft 's cloud momentum hitting next gear of growth, says Wedbush. 158
Microsoft's cloud momentum hitting next gear of growth, says Wedbush. 158
Mistras reports Q 4 EPS 5c, consensus (2c). 208
Motus GI Holdings reports Q4 EPS (12c), consensus (13c). Financial report 306
Nabriva Therapeutics announces publication of analysis of LEAP 2 Phase 3 trial. 349
NewAge reports Q4 revenue $90.4M, consensus $81.02M. 267
Nokia to cut 5,000-10,000 jobs in cost base reset. 219
NOV Inc. lowers Q1 revenue view to $1.20B-$1.25B, consensus $1.32B. Financial report 178
NOV lowers Q1 revenue view to $1.20B-$1.25B, consensus $1.36B. Financial report 176
Nucor sees Q1 EPS $3.00-$3.10, consensus $2.79. Financial report 191
Nurix Therapeutics announces collaboration for drugs to treat pediatric cancers. 212
NuVasive announces continuation of partnership with ISSGF. Clinical report 178
Oil Action: WTI crude. 160
Olin raises Q1 adjusted EBITDA view to $475M-$500M from $400M-$425M. 207
OncoCyte announces publication of data assessing use of DetermaIO. 369
OncoCyte reports Q4 EPS (9c), consensus (11c). Financial report 216
Ontrak appoints CVS Health's Chief Transformation Officer, Mayhew, as CEO. 231
Otelco reports Q4 EPS 42c vs. 58c last year. Financial report 171
PAE names Charles Peiffer interim president and CEO. 198
Partnership with Tiger Woods 'incremental positive' for Take-Two, says KeyBanc. 159
Pliant Therapeutics completes PLN-1474 Phase 1 study, transfer to Novartis. Report 151
Plug Power to restate previously issued financial statements for FY18, FY19. 336
Plum Acquisition Corp. I opens at $9.99, IPO priced at $10. 157
Prelude Therapeutics reports Q4 EPS (45c), consensus (47c). Financial report 209
Priority Technology reports Q4 EPS (1c), two estimates (8c). Financial report 159
Protech Home Medical open two new locations in Florida, New Hampshire. 297
PTC Therapeutics announces two-year data from Part 2 of SUNFISH trial. 346
Quanta's Medolife Rx announces results from efficacy test on polarization tech. 304
Ring Energy sees FY21 sales volume up 3%-8% from previous year. 219
S&T Bancorp extends $50M share repurchase plan. 175
Save Foods files for IPO, applies to list on Nasdaq with symbol 'SVFD'. 195
Sierra Metals receives ITS permit to increase production in Yauricocha mine. 185
Skye Bioscience announces preclinical data on THCVHS. 298
Sony announces Haven, a new games studio led by Jade Raymond. 200
Stifel to rebrand Century Security Associates unit. 241
Surgalign reports Q4 EPS ($1.28), consensus (32c). Financial report 164
The U.S. trade price indexes beat estimates. 153
Today's U.S. reports. 162
Treasury Market Outlook: stocks are mostly firmer amid some stability in bonds. 217
Treasury's $24 B 20-year reopening was very well subscribed. 299
U.S. equity futures are mixed. 158
U.S. industrial production sharply undershot estimates. 169
U.S. retail sales fell -3.0% in February, and declined -2.7%% excluding autos. 184
U.S. retail sales posted outsized February pull-backs. 176
U.S. retail sales preview. 202
U.S. trade price preview. 153
Uber says drivers in U.K. to receive earnings guarantee, holiday pay, pensions. 234
Vaccinex reports 2020 revenue $625,000, two est. $600,000. Financial report 205
Valero, BlackRock team with Navigator on large-scale carbon capture, storage. 158
Verb announces court's preliminarily approval of stockholder's derivative suit. 178
Waldencast Acquisition opens at $10.20, IPO priced at $10 per unit. 185
Watsco to acquire Temperature Equipment Corporation, terms not disclosed. 192
Whole Earth Brands reports Q4 EPS (13c), two est. (7c). 185
WPD Pharmaceuticals engages David Walker to support glioblastoma programs. 183
Yield10 Bioscience reports Q4 EPS (79c), consensus (70c). Financial report 208

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |